BOSTON SCIENTIFIC CORP (BSX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 8B 16B 24B Q3 '21: 11.5B Q4 '21: 11.9B Q1 '22: 12.2B Q2 '22: 12.3B Q3 '22: 12.6B Q4 '22: 12.7B Q1 '23: 13B Q2 '23: 13.4B Q3 '23: 13.8B Q4 '23: 14.2B Q1 '24: 14.7B Q2 '24: 15.2B Q3 '24: 15.9B Q4 '24: 16.7B Q1 '25: 17.6B Q2 '25: 18.5B Q3 '25: 19.4B Q4 '25: 20.1B Q1 '26: 20.6B Q2 '26: 21B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 5B 10B 15B Q3 '21: 7.7B Q4 '21: 8.2B Q1 '22: 8.4B Q2 '22: 8.5B Q3 '22: 8.7B Q4 '22: 8.7B Q1 '23: 9B Q2 '23: 9.3B Q3 '23: 9.5B Q4 '23: 9.9B Q1 '24: 10.2B Q2 '24: 10.5B Q3 '24: 11B Q4 '24: 11.5B Q1 '25: 12.1B Q2 '25: 12.6B Q3 '25: 13.3B Q4 '25: 13.9B Q1 '26: 14.3B Q2 '26: 14.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 1.5B 3B 4.5B Q3 '21: 1.1B Q4 '21: 1.2B Q1 '22: 1.3B Q2 '22: 1.5B Q3 '22: 1.4B Q4 '22: 1.6B Q1 '23: 1.7B Q2 '23: 1.8B Q3 '23: 2.2B Q4 '23: 2.3B Q1 '24: 2.5B Q2 '24: 2.5B Q3 '24: 2.5B Q4 '24: 2.6B Q1 '25: 2.8B Q2 '25: 3.1B Q3 '25: 3.5B Q4 '25: 3.6B Q1 '26: 3.8B Q2 '26: 4.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 1.5B 3B 4.5B Q3 '21: 1.2B Q4 '21: 1B Q1 '22: 810M Q2 '22: 884M Q3 '22: 653M Q4 '22: 698M Q1 '23: 902M Q2 '23: 912M Q3 '23: 1.2B Q4 '23: 1.6B Q1 '24: 1.8B Q2 '24: 1.8B Q3 '24: 1.8B Q4 '24: 1.8B Q1 '25: 2B Q2 '25: 2.5B Q3 '25: 2.8B Q4 '25: 2.9B Q1 '26: 3.6B Q2 '26: 3.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 2.5B 5B 7.5B Q3 '21: 3.7B Q4 '21: 3.7B Q1 '22: 3.8B Q2 '22: 3.8B Q3 '22: 3.9B Q4 '22: 4B Q1 '23: 4B Q2 '23: 4.1B Q3 '23: 4.2B Q4 '23: 4.3B Q1 '24: 4.5B Q2 '24: 4.7B Q3 '24: 4.9B Q4 '24: 5.3B Q1 '25: 5.5B Q2 '25: 5.9B Q3 '25: 6.1B Q4 '25: 6.2B Q1 '26: 6.4B Q2 '26: 6.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 2B 4B 6B Q3 '21: 2.1B Q4 '21: 1.9B Q1 '22: 1.5B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '22: 1.5B Q1 '23: 1.8B Q2 '23: 2.1B Q3 '23: 2.4B Q4 '23: 2.5B Q1 '24: 2.5B Q2 '24: 2.6B Q3 '24: 2.9B Q4 '24: 3.4B Q1 '25: 3.8B Q2 '25: 4.3B Q3 '25: 4.6B Q4 '25: 4.5B Q1 '26: 4.3B Q2 '26: 4.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 1.5B 3B 4.5B Q3 '21: 1.6B Q4 '21: 1.3B Q1 '22: 928M Q2 '22: 593M Q3 '22: 555M Q4 '22: 938M Q1 '23: 1.2B Q2 '23: 1.5B Q3 '23: 1.7B Q4 '23: 1.8B Q1 '24: 1.7B Q2 '24: 1.8B Q3 '24: 2.2B Q4 '24: 2.6B Q1 '25: 3B Q2 '25: 3.5B Q3 '25: 3.8B Q4 '25: 3.7B Q1 '26: 3.5B Q2 '26: 3.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q1 '20: 1.4B Q2 '20: 1.4B Q3 '20: 1.4B Q1 '21: 1.4B Q2 '21: 1.4B Q3 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.4B Q3 '22: 1.4B Q1 '23: 1.4B Q2 '23: 1.5B Q3 '23: 1.5B Q1 '24: 1.5B Q2 '24: 1.5B Q3 '24: 1.5B Q1 '25: 1.5B Q2 '25: 1.5B Q3 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.5B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.90 1.80 2.70 Q3 '21: 0.77 Q4 '21: 0.69 Q1 '22: 0.53 Q2 '22: 0.58 Q3 '22: 0.42 Q4 '22: 0.45 Q1 '23: 0.59 Q2 '23: 0.60 Q3 '23: 0.82 Q4 '23: 1.07 Q1 '24: 1.19 Q2 '24: 1.23 Q3 '24: 1.21 Q4 '24: 1.25 Q1 '25: 1.37 Q2 '25: 1.68 Q3 '25: 1.87 Q4 '25: 1.94 Q1 '26: 2.39 Q2 '26: 2.47 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.